U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H25FN6O6
Molecular Weight 440.4261
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Lagociclovir valactate

SMILES

CC(C)[C@H](N)C(=O)O[C@@H](C)C(=O)OC[C@H]1O[C@H](C[C@@H]1F)N2C=NC3=C2NC(N)=NC3=O

InChI

InChIKey=MPGXKIZZTFGTLP-HGCLJGPKSA-N
InChI=1S/C18H25FN6O6/c1-7(2)12(20)17(28)30-8(3)16(27)29-5-10-9(19)4-11(31-10)25-6-22-13-14(25)23-18(21)24-15(13)26/h6-12H,4-5,20H2,1-3H3,(H3,21,23,24,26)/t8-,9-,10+,11+,12-/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H25FN6O6
Molecular Weight 440.4261
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

LAGOCICLOVIR is a nucleoside reverse transcriptase inhibitor with activity against human immunodeficiency virus and hepatitis B virus.

Approval Year

PubMed

PubMed

TitleDatePubMed
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
1988 Mar
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
1996 Mar
In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase.
2005 Mar
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:49:29 GMT 2023
Edited
by admin
on Sat Dec 16 19:49:29 GMT 2023
Record UNII
4GVR2JJD4R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Lagociclovir valactate
Common Name English
L-Valine, ester with 2′,3′-dideoxy-3′-fluoroguanosine 5′-[(2S)-2-hydroxypropanoate]
Systematic Name English
Code System Code Type Description
PUBCHEM
135525384
Created by admin on Sat Dec 16 19:49:29 GMT 2023 , Edited by admin on Sat Dec 16 19:49:29 GMT 2023
PRIMARY
FDA UNII
4GVR2JJD4R
Created by admin on Sat Dec 16 19:49:29 GMT 2023 , Edited by admin on Sat Dec 16 19:49:29 GMT 2023
PRIMARY
CAS
1001670-19-4
Created by admin on Sat Dec 16 19:49:29 GMT 2023 , Edited by admin on Sat Dec 16 19:49:29 GMT 2023
PRIMARY
Related Record Type Details
METABOLITE ACTIVE -> PRODRUG
Related Record Type Details
ACTIVE MOIETY